Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $25.37. The company's market cap stands at 144.54B, with a P/E ratio of 19.59 and a dividend yield of 6.7%.
On 2026-06-03, Pfizer(PFE) stock moved within a range of $25.29 to $25.62. With shares now at $25.37, the stock is trading +0.3% above its intraday low and -1.0% below the session's peak.
Trading activity shows a volume of 30.5M, compared to an average daily volume of 32.8M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.06.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.06.
PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings a...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings a...
Pfizer vs Merck: Chasing High Yield vs Higher Returns By Vandita Jadeja Published Jun 3, 10:06AM EDT Quick Read PFE yields 6.58% at a forward P/E of 9, while...
Analyst ratings
55%
of 29 ratingsMore PFE News
Key Points Both are working hard to get around patent cliffs. One of them seems to have made more progress on that front. 10 stocks we like better than Brist...
Why Pfizer’s Current Price May Be Too Cheap to Ignore By Vandita Jadeja Published Jun 2, 10:03AM EDT Quick Read Pfizer (PFE) trades at $26.18 with a 24/7 Wall...
Pfizer reported new seven-year data from the Phase 3 CROWN trial at ASCO 2026, highlighting LORBRENA for untreated ALK-positive advanced non small cell lung can...
In trading on Monday, shares of Pfizer Inc (Symbol: PFE) crossed below their 200 day moving average of $25.83, changing hands as low as $25.48 per share. Pfizer...
Key Points AbbVie leverages a strong pipeline in immunology and oncology to drive nearly $61.2 billion in annual revenue. Pfizer maintains a diverse portfolio...
Key Points Pfizer could flourish under a Warsh-led Fed for several reasons. However, the drugmaker won't be a slam-dunk winner, in part because of its debt an...
UBS analyst Michael Yee has maintained their neutral stance on PFE stock, giving a Hold rating on May 28. Unlock trusted, data-backed investing tools with TipR...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.